Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

Blood

Volumn 113, Issue 23, 2009, Pages 6011-6014

  Díez Martín, José L ^a   Balsalobre, Pascual ^a   Re, Alessandro ^b   Michieli, Mariagrazia ^c   Ribera, José M ^d   Canals, Carmen ^e   Conde, Eulogio ^f   Rosselet, Anne ^g   Gabriel, Ian ^h   Varela, Rosario ⁱ   Allione, Bernardino ^j   Cwynarski, Kate ^k   Genet, Philippe ^l   Espigado, Ildefonso ^m   Biron, Pierre ⁿ   Schmitz, Norbert ^o   Hunter, Anne E ^p   Ferrant, Augustin ^q   Guillerm, Gaelle ^r   Hentrich, Mark ^s   Jurado, Manuel ^t   Fernández, Pascual ^u   Serrano, David ^a   Rossi, Giuseppe ^b   Sureda, Anna ^e   more..

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b SPEDALI CIVILI   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e European Group for Blood and Marrow Transplantation Lymphoma Working Party   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

ⁱ HOSPITAL JUAN CANALEJO   (Spain)

^j Ospedale Civile SS Antonio e Biagio   (Italy)

^k ROYAL FREE HOSPITAL   (United Kingdom)

^l CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^m HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁿ CENTRE LÉON BÉRARD   (France)

^o DEPARTMENT OF CARDIOLOGY   (Germany)

^p LEICESTER ROYAL INFIRMARY   (United Kingdom)

^q CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^r CHU MORVAN   (France)

^s Klinikum Harlaching   (Germany)

^t HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^u HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; WHOLE BODY RADIATION; AUTOTRANSPLANTATION; COMPARATIVE STUDY; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ADULT; FEMALE; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 67651125052     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-195388     Document Type: Article

References (18)

1. Beral V, Peterman T, Berkelman R, et al. AIDS-associated non-Hodgkin's lymphoma. Lancet. 1991;337:805-809.
2. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immune suppression in adults. JAMA. 2001;285:1736-1745. (Pubitemid 32259908)
3. Levine AM. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol. 2000;27:442-453. (Pubitemid 30626443)
4. Navarro JT, Ribera JM, Oriol A, et al. International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin lymphoma treated with CHOP: a multivariate study of 46 patients. Haematologica. 1998;83:508-513. (Pubitemid 28331168)
5. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood. 2001;98:3406-3412.
6. Navarro JT, Ribera JM, Oriol A, et al. Influence of highly active antiretroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin lymphoma treated with cyclophosphamide, hydroxydoxorubicine, vincristine and prednisone. Br J Haematol. 2001;112:909-915. (Pubitemid 32322915)
7. Hoffmann C, Wolf E, Fätkenheuer G, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS. 2003;17:1521-1529. (Pubitemid 36900553)
8. Bi J, Espina BM, Tulpule A, et al. High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin lymphoma. J Acquir Immune Defic Syndr. 2001;28:416-421. (Pubitemid 34033191)
9. Spina M, Vaccher E, Juzbasic S, et al. Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients. Cancer. 2001;92:200-206. (Pubitemid 32623058)
10. Gabarre J, Marcelin AG, Azar N, et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica. 2004;89:1100-1108. (Pubitemid 39295481)
11. Krishnan A, Molina A, Zaia J, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005;105:874-878. (Pubitemid 40070778)
12. Re A, Cattaneo C, Michieli M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol. 2003;21:4423-4427. (Pubitemid 46621820)
13. Serrano D, Carrion R, Balsalobre P, et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol. 2005;33:487-494. (Pubitemid 40387632)
14. Balsalobre P, Diez-Martin JL, Re A, et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma. J Clin Oncol. 2009;27:2192-2198.
15. - Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) patients undergoing an autologous peripheral blood stem cell transplantation (ASCT): a retrospective analysis of the EBMT Lymphoma Working Party. Blood. 2007;110:15a. Abstract 24.
16. Vose JM, Rizzo DJ, Tao-Wu J, et al. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant. 2004;10:116-127. (Pubitemid 38145865)
17. NademaneeA, Molina A, O'Donnell MR, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. Blood. 1997;90:3844-3852.
18. Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med. 2004;350:1287-1295. (Pubitemid 38375363)